- Home
- / EXACT Therapeutics
EXACT Therapeutics
Stock Price
€0.5
2024-10-29
Market Capitalization
€15.6 M
2024-10-29
EXACT Therapeutics Summary
Company Summary
- Overview
- EXACT Therapeutics is a biopharmaceutical company that develops ultrasound-mediated technology platforms. It offers therapeutic enhancement for chemotherapy and immunotherapy, infectious diseases, and neurological conditions.
- Type
- Public
- Status
- Active
- Founded
- 2012
- Website
- https://www.exact-tx.com
- Cybersecurity rating
Table of Contents
EXACT Therapeutics Financials
Summary Financials
- Gross profit (FY, 2025)
- kr59.0K
- Net income (FY, 2025)
- (kr87.0M)
- Cash (FY, 2025)
- kr23.5M
- EBIT (FY, 2025)
- (kr84.9M)
- Enterprise value
- ($7.4M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026